Medical Devices & Consumables
Global Cell Therapy and Tissue Engineering Market Insights, Forecast to 2030
- Dec 27, 24
- ID: 775175
- Pages: 127
- Figures: 153
- Views: 2
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
Market Analysis and Insights: Global Cell Therapy and Tissue Engineering Market
The global Cell Therapy and Tissue Engineering market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
Report Covers:
This report presents an overview of global market for Cell Therapy and Tissue Engineering market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cell Therapy and Tissue Engineering, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Therapy and Tissue Engineering, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Therapy and Tissue Engineering revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cell Therapy and Tissue Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cell Therapy and Tissue Engineering revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Segment by Type
Cell Therapy
Tissue Engineering
Segment by Application
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Therapy and Tissue Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy and Tissue Engineering companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy and Tissue Engineering revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Cell Therapy and Tissue Engineering Market
The global Cell Therapy and Tissue Engineering market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
Report Covers:
This report presents an overview of global market for Cell Therapy and Tissue Engineering market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cell Therapy and Tissue Engineering, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Therapy and Tissue Engineering, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Therapy and Tissue Engineering revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cell Therapy and Tissue Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cell Therapy and Tissue Engineering revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Segment by Type
Cell Therapy
Tissue Engineering
Segment by Application
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell Therapy and Tissue Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy and Tissue Engineering companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapy and Tissue Engineering revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.3 Market by Application
1.3.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cell Defects
1.3.3 Genetic Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Tissue Malignancies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy and Tissue Engineering Market Perspective (2019-2030)
2.2 Global Cell Therapy and Tissue Engineering Growth Trends by Region
2.2.1 Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Therapy and Tissue Engineering Historic Market Size by Region (2019-2024)
2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030)
2.3 Cell Therapy and Tissue Engineering Market Dynamics
2.3.1 Cell Therapy and Tissue Engineering Industry Trends
2.3.2 Cell Therapy and Tissue Engineering Market Drivers
2.3.3 Cell Therapy and Tissue Engineering Market Challenges
2.3.4 Cell Therapy and Tissue Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell Therapy and Tissue Engineering by Players
3.1.1 Global Cell Therapy and Tissue Engineering Revenue by Players (2019-2024)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2019-2024)
3.2 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell Therapy and Tissue Engineering, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
3.4.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2023
3.5 Global Key Players of Cell Therapy and Tissue Engineering Head office and Area Served
3.6 Global Key Players of Cell Therapy and Tissue Engineering, Product and Application
3.7 Global Key Players of Cell Therapy and Tissue Engineering, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy and Tissue Engineering Breakdown Data by Type
4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2019-2024)
4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030)
5 Cell Therapy and Tissue Engineering Breakdown Data by Application
5.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Application (2019-2024)
5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Therapy and Tissue Engineering Market Size (2019-2030)
6.2 North America Cell Therapy and Tissue Engineering Market Size by Type
6.2.1 North America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
6.2.2 North America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
6.2.3 North America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
6.3 North America Cell Therapy and Tissue Engineering Market Size by Application
6.3.1 North America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
6.3.2 North America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
6.3.3 North America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
6.4 North America Cell Therapy and Tissue Engineering Market Size by Country
6.4.1 North America Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
6.4.3 North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cell Therapy and Tissue Engineering Market Size (2019-2030)
7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type
7.2.1 Europe Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
7.2.2 Europe Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
7.2.3 Europe Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application
7.3.1 Europe Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
7.3.2 Europe Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
7.3.3 Europe Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
7.4 Europe Cell Therapy and Tissue Engineering Market Size by Country
7.4.1 Europe Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
7.4.3 Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell Therapy and Tissue Engineering Market Size (2019-2030)
8.2 China Cell Therapy and Tissue Engineering Market Size by Type
8.2.1 China Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
8.2.2 China Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
8.2.3 China Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
8.3 China Cell Therapy and Tissue Engineering Market Size by Application
8.3.1 China Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
8.3.2 China Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
8.3.3 China Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cell Therapy and Tissue Engineering Market Size (2019-2030)
9.2 Asia Cell Therapy and Tissue Engineering Market Size by Type
9.2.1 Asia Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
9.2.2 Asia Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
9.2.3 Asia Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
9.3 Asia Cell Therapy and Tissue Engineering Market Size by Application
9.3.1 Asia Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
9.3.2 Asia Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
9.3.3 Asia Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
9.4 Asia Cell Therapy and Tissue Engineering Market Size by Region
9.4.1 Asia Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cell Therapy and Tissue Engineering Market Size by Region (2019-2024)
9.4.3 Asia Cell Therapy and Tissue Engineering Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Betalin Therapeutics
11.1.1 Betalin Therapeutics Company Details
11.1.2 Betalin Therapeutics Business Overview
11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
11.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.1.5 Betalin Therapeutics Recent Developments
11.2 BioCardia, Inc
11.2.1 BioCardia, Inc Company Details
11.2.2 BioCardia, Inc Business Overview
11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
11.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.2.5 BioCardia, Inc Recent Developments
11.3 BioReliance Corporation
11.3.1 BioReliance Corporation Company Details
11.3.2 BioReliance Corporation Business Overview
11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
11.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.3.5 BioReliance Corporation Recent Developments
11.4 Biosolution Co.
11.4.1 Biosolution Co. Company Details
11.4.2 Biosolution Co. Business Overview
11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
11.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.4.5 Biosolution Co. Recent Developments
11.5 Brainstorm Cell Therapeutics, Inc
11.5.1 Brainstorm Cell Therapeutics, Inc Company Details
11.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.5.5 Brainstorm Cell Therapeutics, Inc Recent Developments
11.6 MaxCyte, Inc
11.6.1 MaxCyte, Inc Company Details
11.6.2 MaxCyte, Inc Business Overview
11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
11.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.6.5 MaxCyte, Inc Recent Developments
11.7 Medigene AG
11.7.1 Medigene AG Company Details
11.7.2 Medigene AG Business Overview
11.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
11.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.7.5 Medigene AG Recent Developments
11.8 MEDIPOST CO.
11.8.1 MEDIPOST CO. Company Details
11.8.2 MEDIPOST CO. Business Overview
11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
11.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.8.5 MEDIPOST CO. Recent Developments
11.9 Mesoblast Limited
11.9.1 Mesoblast Limited Company Details
11.9.2 Mesoblast Limited Business Overview
11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
11.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.9.5 Mesoblast Limited Recent Developments
11.10 Miromatrix Medical, Inc.
11.10.1 Miromatrix Medical, Inc. Company Details
11.10.2 Miromatrix Medical, Inc. Business Overview
11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
11.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.10.5 Miromatrix Medical, Inc. Recent Developments
11.11 MolMed S.p.A
11.11.1 MolMed S.p.A Company Details
11.11.2 MolMed S.p.A Business Overview
11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
11.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.11.5 MolMed S.p.A Recent Developments
11.12 Mustang Bio, Inc
11.12.1 Mustang Bio, Inc Company Details
11.12.2 Mustang Bio, Inc Business Overview
11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
11.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.12.5 Mustang Bio, Inc Recent Developments
11.13 NantKwest, Inc.
11.13.1 NantKwest, Inc. Company Details
11.13.2 NantKwest, Inc. Business Overview
11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
11.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.13.5 NantKwest, Inc. Recent Developments
11.14 Neuralstem, Inc
11.14.1 Neuralstem, Inc Company Details
11.14.2 Neuralstem, Inc Business Overview
11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
11.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.14.5 Neuralstem, Inc Recent Developments
11.15 NexImmune, Inc.
11.15.1 NexImmune, Inc. Company Details
11.15.2 NexImmune, Inc. Business Overview
11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
11.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.15.5 NexImmune, Inc. Recent Developments
11.16 Nohla Therapeutics, Inc
11.16.1 Nohla Therapeutics, Inc Company Details
11.16.2 Nohla Therapeutics, Inc Business Overview
11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.16.5 Nohla Therapeutics, Inc Recent Developments
11.17 ReNeuron Group plc
11.17.1 ReNeuron Group plc Company Details
11.17.2 ReNeuron Group plc Business Overview
11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.17.5 ReNeuron Group plc Recent Developments
11.18 Richter-Helm BioLogics GmbH & Co. KG
11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
11.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments
11.19 RoosterBio, Inc
11.19.1 RoosterBio, Inc Company Details
11.19.2 RoosterBio, Inc Business Overview
11.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.19.5 RoosterBio, Inc Recent Developments
11.20 RoslinCT
11.20.1 RoslinCT Company Details
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.20.5 RoslinCT Recent Developments
11.21 Rubius Therapeutics, Inc.
11.21.1 Rubius Therapeutics, Inc. Company Details
11.21.2 Rubius Therapeutics, Inc. Business Overview
11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.21.5 Rubius Therapeutics, Inc. Recent Developments
11.22 Sangamo Therapeutics, Inc
11.22.1 Sangamo Therapeutics, Inc Company Details
11.22.2 Sangamo Therapeutics, Inc Business Overview
11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.22.5 Sangamo Therapeutics, Inc Recent Developments
11.23 Voyager Therapeutics, Inc
11.23.1 Voyager Therapeutics, Inc Company Details
11.23.2 Voyager Therapeutics, Inc Business Overview
11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.23.5 Voyager Therapeutics, Inc Recent Developments
11.24 Waisman Biomanufacturing
11.24.1 Waisman Biomanufacturing Company Details
11.24.2 Waisman Biomanufacturing Business Overview
11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
11.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.24.5 Waisman Biomanufacturing Recent Developments
11.25 WindMIL Therapeutics, Inc.
11.25.1 WindMIL Therapeutics, Inc. Company Details
11.25.2 WindMIL Therapeutics, Inc. Business Overview
11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.25.5 WindMIL Therapeutics, Inc. Recent Developments
11.26 Wuxi App Tec, Inc.
11.26.1 Wuxi App Tec, Inc. Company Details
11.26.2 Wuxi App Tec, Inc. Business Overview
11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
11.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.26.5 Wuxi App Tec, Inc. Recent Developments
11.27 ReNeuron Group plc
11.27.1 ReNeuron Group plc Company Details
11.27.2 ReNeuron Group plc Business Overview
11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.27.5 ReNeuron Group plc Recent Developments
11.28 Richter-Helm BioLogics GmbH & Co. KG
11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
11.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments
11.29 RoosterBio, Inc
11.29.1 RoosterBio, Inc Company Details
11.29.2 RoosterBio, Inc Business Overview
11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.29.5 RoosterBio, Inc Recent Developments
11.30 RoslinCT
11.30.1 RoslinCT Company Details
11.30.2 RoslinCT Business Overview
11.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.30.5 RoslinCT Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.3 Market by Application
1.3.1 Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cell Defects
1.3.3 Genetic Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Tissue Malignancies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Therapy and Tissue Engineering Market Perspective (2019-2030)
2.2 Global Cell Therapy and Tissue Engineering Growth Trends by Region
2.2.1 Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Therapy and Tissue Engineering Historic Market Size by Region (2019-2024)
2.2.3 Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030)
2.3 Cell Therapy and Tissue Engineering Market Dynamics
2.3.1 Cell Therapy and Tissue Engineering Industry Trends
2.3.2 Cell Therapy and Tissue Engineering Market Drivers
2.3.3 Cell Therapy and Tissue Engineering Market Challenges
2.3.4 Cell Therapy and Tissue Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell Therapy and Tissue Engineering by Players
3.1.1 Global Cell Therapy and Tissue Engineering Revenue by Players (2019-2024)
3.1.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Players (2019-2024)
3.2 Global Cell Therapy and Tissue Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell Therapy and Tissue Engineering, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cell Therapy and Tissue Engineering Market Concentration Ratio
3.4.1 Global Cell Therapy and Tissue Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy and Tissue Engineering Revenue in 2023
3.5 Global Key Players of Cell Therapy and Tissue Engineering Head office and Area Served
3.6 Global Key Players of Cell Therapy and Tissue Engineering, Product and Application
3.7 Global Key Players of Cell Therapy and Tissue Engineering, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Therapy and Tissue Engineering Breakdown Data by Type
4.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Type (2019-2024)
4.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030)
5 Cell Therapy and Tissue Engineering Breakdown Data by Application
5.1 Global Cell Therapy and Tissue Engineering Historic Market Size by Application (2019-2024)
5.2 Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Therapy and Tissue Engineering Market Size (2019-2030)
6.2 North America Cell Therapy and Tissue Engineering Market Size by Type
6.2.1 North America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
6.2.2 North America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
6.2.3 North America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
6.3 North America Cell Therapy and Tissue Engineering Market Size by Application
6.3.1 North America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
6.3.2 North America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
6.3.3 North America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
6.4 North America Cell Therapy and Tissue Engineering Market Size by Country
6.4.1 North America Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
6.4.3 North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cell Therapy and Tissue Engineering Market Size (2019-2030)
7.2 Europe Cell Therapy and Tissue Engineering Market Size by Type
7.2.1 Europe Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
7.2.2 Europe Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
7.2.3 Europe Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
7.3 Europe Cell Therapy and Tissue Engineering Market Size by Application
7.3.1 Europe Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
7.3.2 Europe Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
7.3.3 Europe Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
7.4 Europe Cell Therapy and Tissue Engineering Market Size by Country
7.4.1 Europe Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
7.4.3 Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell Therapy and Tissue Engineering Market Size (2019-2030)
8.2 China Cell Therapy and Tissue Engineering Market Size by Type
8.2.1 China Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
8.2.2 China Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
8.2.3 China Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
8.3 China Cell Therapy and Tissue Engineering Market Size by Application
8.3.1 China Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
8.3.2 China Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
8.3.3 China Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cell Therapy and Tissue Engineering Market Size (2019-2030)
9.2 Asia Cell Therapy and Tissue Engineering Market Size by Type
9.2.1 Asia Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
9.2.2 Asia Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
9.2.3 Asia Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
9.3 Asia Cell Therapy and Tissue Engineering Market Size by Application
9.3.1 Asia Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
9.3.2 Asia Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
9.3.3 Asia Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
9.4 Asia Cell Therapy and Tissue Engineering Market Size by Region
9.4.1 Asia Cell Therapy and Tissue Engineering Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cell Therapy and Tissue Engineering Market Size by Region (2019-2024)
9.4.3 Asia Cell Therapy and Tissue Engineering Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Betalin Therapeutics
11.1.1 Betalin Therapeutics Company Details
11.1.2 Betalin Therapeutics Business Overview
11.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Introduction
11.1.4 Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.1.5 Betalin Therapeutics Recent Developments
11.2 BioCardia, Inc
11.2.1 BioCardia, Inc Company Details
11.2.2 BioCardia, Inc Business Overview
11.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Introduction
11.2.4 BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.2.5 BioCardia, Inc Recent Developments
11.3 BioReliance Corporation
11.3.1 BioReliance Corporation Company Details
11.3.2 BioReliance Corporation Business Overview
11.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Introduction
11.3.4 BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.3.5 BioReliance Corporation Recent Developments
11.4 Biosolution Co.
11.4.1 Biosolution Co. Company Details
11.4.2 Biosolution Co. Business Overview
11.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Introduction
11.4.4 Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.4.5 Biosolution Co. Recent Developments
11.5 Brainstorm Cell Therapeutics, Inc
11.5.1 Brainstorm Cell Therapeutics, Inc Company Details
11.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
11.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.5.4 Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.5.5 Brainstorm Cell Therapeutics, Inc Recent Developments
11.6 MaxCyte, Inc
11.6.1 MaxCyte, Inc Company Details
11.6.2 MaxCyte, Inc Business Overview
11.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Introduction
11.6.4 MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.6.5 MaxCyte, Inc Recent Developments
11.7 Medigene AG
11.7.1 Medigene AG Company Details
11.7.2 Medigene AG Business Overview
11.7.3 Medigene AG Cell Therapy and Tissue Engineering Introduction
11.7.4 Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.7.5 Medigene AG Recent Developments
11.8 MEDIPOST CO.
11.8.1 MEDIPOST CO. Company Details
11.8.2 MEDIPOST CO. Business Overview
11.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Introduction
11.8.4 MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.8.5 MEDIPOST CO. Recent Developments
11.9 Mesoblast Limited
11.9.1 Mesoblast Limited Company Details
11.9.2 Mesoblast Limited Business Overview
11.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Introduction
11.9.4 Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.9.5 Mesoblast Limited Recent Developments
11.10 Miromatrix Medical, Inc.
11.10.1 Miromatrix Medical, Inc. Company Details
11.10.2 Miromatrix Medical, Inc. Business Overview
11.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Introduction
11.10.4 Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.10.5 Miromatrix Medical, Inc. Recent Developments
11.11 MolMed S.p.A
11.11.1 MolMed S.p.A Company Details
11.11.2 MolMed S.p.A Business Overview
11.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Introduction
11.11.4 MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.11.5 MolMed S.p.A Recent Developments
11.12 Mustang Bio, Inc
11.12.1 Mustang Bio, Inc Company Details
11.12.2 Mustang Bio, Inc Business Overview
11.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Introduction
11.12.4 Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.12.5 Mustang Bio, Inc Recent Developments
11.13 NantKwest, Inc.
11.13.1 NantKwest, Inc. Company Details
11.13.2 NantKwest, Inc. Business Overview
11.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Introduction
11.13.4 NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.13.5 NantKwest, Inc. Recent Developments
11.14 Neuralstem, Inc
11.14.1 Neuralstem, Inc Company Details
11.14.2 Neuralstem, Inc Business Overview
11.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Introduction
11.14.4 Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.14.5 Neuralstem, Inc Recent Developments
11.15 NexImmune, Inc.
11.15.1 NexImmune, Inc. Company Details
11.15.2 NexImmune, Inc. Business Overview
11.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Introduction
11.15.4 NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.15.5 NexImmune, Inc. Recent Developments
11.16 Nohla Therapeutics, Inc
11.16.1 Nohla Therapeutics, Inc Company Details
11.16.2 Nohla Therapeutics, Inc Business Overview
11.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.16.4 Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.16.5 Nohla Therapeutics, Inc Recent Developments
11.17 ReNeuron Group plc
11.17.1 ReNeuron Group plc Company Details
11.17.2 ReNeuron Group plc Business Overview
11.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.17.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.17.5 ReNeuron Group plc Recent Developments
11.18 Richter-Helm BioLogics GmbH & Co. KG
11.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
11.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.18.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.18.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments
11.19 RoosterBio, Inc
11.19.1 RoosterBio, Inc Company Details
11.19.2 RoosterBio, Inc Business Overview
11.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.19.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.19.5 RoosterBio, Inc Recent Developments
11.20 RoslinCT
11.20.1 RoslinCT Company Details
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.20.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.20.5 RoslinCT Recent Developments
11.21 Rubius Therapeutics, Inc.
11.21.1 Rubius Therapeutics, Inc. Company Details
11.21.2 Rubius Therapeutics, Inc. Business Overview
11.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.21.4 Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.21.5 Rubius Therapeutics, Inc. Recent Developments
11.22 Sangamo Therapeutics, Inc
11.22.1 Sangamo Therapeutics, Inc Company Details
11.22.2 Sangamo Therapeutics, Inc Business Overview
11.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.22.4 Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.22.5 Sangamo Therapeutics, Inc Recent Developments
11.23 Voyager Therapeutics, Inc
11.23.1 Voyager Therapeutics, Inc Company Details
11.23.2 Voyager Therapeutics, Inc Business Overview
11.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Introduction
11.23.4 Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.23.5 Voyager Therapeutics, Inc Recent Developments
11.24 Waisman Biomanufacturing
11.24.1 Waisman Biomanufacturing Company Details
11.24.2 Waisman Biomanufacturing Business Overview
11.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Introduction
11.24.4 Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.24.5 Waisman Biomanufacturing Recent Developments
11.25 WindMIL Therapeutics, Inc.
11.25.1 WindMIL Therapeutics, Inc. Company Details
11.25.2 WindMIL Therapeutics, Inc. Business Overview
11.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Introduction
11.25.4 WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.25.5 WindMIL Therapeutics, Inc. Recent Developments
11.26 Wuxi App Tec, Inc.
11.26.1 Wuxi App Tec, Inc. Company Details
11.26.2 Wuxi App Tec, Inc. Business Overview
11.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Introduction
11.26.4 Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.26.5 Wuxi App Tec, Inc. Recent Developments
11.27 ReNeuron Group plc
11.27.1 ReNeuron Group plc Company Details
11.27.2 ReNeuron Group plc Business Overview
11.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Introduction
11.27.4 ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.27.5 ReNeuron Group plc Recent Developments
11.28 Richter-Helm BioLogics GmbH & Co. KG
11.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Details
11.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
11.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Introduction
11.28.4 Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.28.5 Richter-Helm BioLogics GmbH & Co. KG Recent Developments
11.29 RoosterBio, Inc
11.29.1 RoosterBio, Inc Company Details
11.29.2 RoosterBio, Inc Business Overview
11.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Introduction
11.29.4 RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.29.5 RoosterBio, Inc Recent Developments
11.30 RoslinCT
11.30.1 RoslinCT Company Details
11.30.2 RoslinCT Business Overview
11.30.3 RoslinCT Cell Therapy and Tissue Engineering Introduction
11.30.4 RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024)
11.30.5 RoslinCT Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell Therapy and Tissue Engineering Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cell Therapy and Tissue Engineering Market Share by Region (2019-2024)
Table 8. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cell Therapy and Tissue Engineering Market Share by Region (2025-2030)
Table 10. Cell Therapy and Tissue Engineering Market Trends
Table 11. Cell Therapy and Tissue Engineering Market Drivers
Table 12. Cell Therapy and Tissue Engineering Market Challenges
Table 13. Cell Therapy and Tissue Engineering Market Restraints
Table 14. Global Cell Therapy and Tissue Engineering Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cell Therapy and Tissue Engineering Revenue Share by Players (2019-2024)
Table 16. Global Top Cell Therapy and Tissue Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2023)
Table 17. Global Cell Therapy and Tissue Engineering Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Cell Therapy and Tissue Engineering Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Cell Therapy and Tissue Engineering, Headquarters and Area Served
Table 20. Global Key Players of Cell Therapy and Tissue Engineering, Product and Application
Table 21. Global Key Players of Cell Therapy and Tissue Engineering, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2019-2024)
Table 25. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2025-2030)
Table 27. Global Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cell Therapy and Tissue Engineering Revenue Share by Application (2019-2024)
Table 29. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cell Therapy and Tissue Engineering Revenue Share by Application (2025-2030)
Table 31. North America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Cell Therapy and Tissue Engineering Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Cell Therapy and Tissue Engineering Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)
Table 63. Betalin Therapeutics Company Details
Table 64. Betalin Therapeutics Business Overview
Table 65. Betalin Therapeutics Cell Therapy and Tissue Engineering Product
Table 66. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 67. Betalin Therapeutics Recent Developments
Table 68. BioCardia, Inc Company Details
Table 69. BioCardia, Inc Business Overview
Table 70. BioCardia, Inc Cell Therapy and Tissue Engineering Product
Table 71. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 72. BioCardia, Inc Recent Developments
Table 73. BioReliance Corporation Company Details
Table 74. BioReliance Corporation Business Overview
Table 75. BioReliance Corporation Cell Therapy and Tissue Engineering Product
Table 76. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 77. BioReliance Corporation Recent Developments
Table 78. Biosolution Co. Company Details
Table 79. Biosolution Co. Business Overview
Table 80. Biosolution Co. Cell Therapy and Tissue Engineering Product
Table 81. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 82. Biosolution Co. Recent Developments
Table 83. Brainstorm Cell Therapeutics, Inc Company Details
Table 84. Brainstorm Cell Therapeutics, Inc Business Overview
Table 85. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 86. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 87. Brainstorm Cell Therapeutics, Inc Recent Developments
Table 88. MaxCyte, Inc Company Details
Table 89. MaxCyte, Inc Business Overview
Table 90. MaxCyte, Inc Cell Therapy and Tissue Engineering Product
Table 91. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 92. MaxCyte, Inc Recent Developments
Table 93. Medigene AG Company Details
Table 94. Medigene AG Business Overview
Table 95. Medigene AG Cell Therapy and Tissue Engineering Product
Table 96. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 97. Medigene AG Recent Developments
Table 98. MEDIPOST CO. Company Details
Table 99. MEDIPOST CO. Business Overview
Table 100. MEDIPOST CO. Cell Therapy and Tissue Engineering Product
Table 101. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 102. MEDIPOST CO. Recent Developments
Table 103. Mesoblast Limited Company Details
Table 104. Mesoblast Limited Business Overview
Table 105. Mesoblast Limited Cell Therapy and Tissue Engineering Product
Table 106. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 107. Mesoblast Limited Recent Developments
Table 108. Miromatrix Medical, Inc. Company Details
Table 109. Miromatrix Medical, Inc. Business Overview
Table 110. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product
Table 111. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 112. Miromatrix Medical, Inc. Recent Developments
Table 113. MolMed S.p.A Company Details
Table 114. MolMed S.p.A Business Overview
Table 115. MolMed S.p.A Cell Therapy and Tissue Engineering Product
Table 116. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 117. MolMed S.p.A Recent Developments
Table 118. Mustang Bio, Inc Company Details
Table 119. Mustang Bio, Inc Business Overview
Table 120. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product
Table 121. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 122. Mustang Bio, Inc Recent Developments
Table 123. NantKwest, Inc. Company Details
Table 124. NantKwest, Inc. Business Overview
Table 125. NantKwest, Inc. Cell Therapy and Tissue Engineering Product
Table 126. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 127. NantKwest, Inc. Recent Developments
Table 128. Neuralstem, Inc Company Details
Table 129. Neuralstem, Inc Business Overview
Table 130. Neuralstem, Inc Cell Therapy and Tissue Engineering Product
Table 131. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 132. Neuralstem, Inc Recent Developments
Table 133. NexImmune, Inc. Company Details
Table 134. NexImmune, Inc. Business Overview
Table 135. NexImmune, Inc. Cell Therapy and Tissue Engineering Product
Table 136. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 137. NexImmune, Inc. Recent Developments
Table 138. Nohla Therapeutics, Inc Company Details
Table 139. Nohla Therapeutics, Inc Business Overview
Table 140. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 141. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 142. Nohla Therapeutics, Inc Recent Developments
Table 143. ReNeuron Group plc Company Details
Table 144. ReNeuron Group plc Business Overview
Table 145. ReNeuron Group plc Cell Therapy and Tissue Engineering Product
Table 146. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 147. ReNeuron Group plc Recent Developments
Table 148. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 149. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 150. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product
Table 151. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 152. Richter-Helm BioLogics GmbH & Co. KG Recent Developments
Table 153. RoosterBio, Inc Company Details
Table 154. RoosterBio, Inc Business Overview
Table 155. RoosterBio, Inc Cell Therapy and Tissue Engineering Product
Table 156. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 157. RoosterBio, Inc Recent Developments
Table 158. RoslinCT Company Details
Table 159. RoslinCT Business Overview
Table 160. RoslinCT Cell Therapy and Tissue Engineering Product
Table 161. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 162. RoslinCT Recent Developments
Table 163. Rubius Therapeutics, Inc. Company Details
Table 164. Rubius Therapeutics, Inc. Business Overview
Table 165. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product
Table 166. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 167. Rubius Therapeutics, Inc. Recent Developments
Table 168. Sangamo Therapeutics, Inc Company Details
Table 169. Sangamo Therapeutics, Inc Business Overview
Table 170. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 171. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 172. Sangamo Therapeutics, Inc Recent Developments
Table 173. Voyager Therapeutics, Inc Company Details
Table 174. Voyager Therapeutics, Inc Business Overview
Table 175. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 176. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 177. Voyager Therapeutics, Inc Recent Developments
Table 178. Waisman Biomanufacturing Company Details
Table 179. Waisman Biomanufacturing Business Overview
Table 180. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product
Table 181. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 182. Waisman Biomanufacturing Recent Developments
Table 183. WindMIL Therapeutics, Inc. Company Details
Table 184. WindMIL Therapeutics, Inc. Business Overview
Table 185. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product
Table 186. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 187. WindMIL Therapeutics, Inc. Recent Developments
Table 188. Wuxi App Tec, Inc. Company Details
Table 189. Wuxi App Tec, Inc. Business Overview
Table 190. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product
Table 191. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 192. Wuxi App Tec, Inc. Recent Developments
Table 193. ReNeuron Group plc Company Details
Table 194. ReNeuron Group plc Business Overview
Table 195. ReNeuron Group plc Cell Therapy and Tissue Engineering Product
Table 196. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 197. ReNeuron Group plc Recent Developments
Table 198. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 199. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 200. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product
Table 201. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 202. Richter-Helm BioLogics GmbH & Co. KG Recent Developments
Table 203. RoosterBio, Inc Company Details
Table 204. RoosterBio, Inc Business Overview
Table 205. RoosterBio, Inc Cell Therapy and Tissue Engineering Product
Table 206. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 207. RoosterBio, Inc Recent Developments
Table 208. RoslinCT Company Details
Table 209. RoslinCT Business Overview
Table 210. RoslinCT Cell Therapy and Tissue Engineering Product
Table 211. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 212. RoslinCT Recent Developments
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Cell Therapy and Tissue Engineering Market Share by Type: 2023 VS 2030
Figure 3. Cell Therapy Features
Figure 4. Tissue Engineering Features
Figure 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Cell Therapy and Tissue Engineering Market Share by Application: 2023 VS 2030
Figure 7. Cell Defects Case Studies
Figure 8. Genetic Diseases Case Studies
Figure 9. Neurodegenerative Diseases Case Studies
Figure 10. Tissue Malignancies Case Studies
Figure 11. Others Case Studies
Figure 12. Cell Therapy and Tissue Engineering Report Years Considered
Figure 13. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cell Therapy and Tissue Engineering Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Region: 2023 VS 2030
Figure 16. Global Cell Therapy and Tissue Engineering Market Share by Players in 2023
Figure 17. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2023
Figure 19. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 21. North America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 22. North America Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)
Figure 23. United States Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 27. Europe Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 28. Europe Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)
Figure 29. Germany Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 37. China Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 38. Asia Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 40. Asia Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 41. Asia Cell Therapy and Tissue Engineering Market Share by Region (2019-2030)
Figure 42. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)
Figure 52. Brazil Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 59. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 60. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 61. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 62. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 63. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 64. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 65. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 66. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 67. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 68. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 69. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 70. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 71. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 72. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 73. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 74. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 75. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 76. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 77. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 78. Rubius Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 79. Sangamo Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 80. Voyager Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 81. Waisman Biomanufacturing Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 82. WindMIL Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 83. Wuxi App Tec, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 84. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 85. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 86. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 87. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Table 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell Therapy and Tissue Engineering Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cell Therapy and Tissue Engineering Market Share by Region (2019-2024)
Table 8. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cell Therapy and Tissue Engineering Market Share by Region (2025-2030)
Table 10. Cell Therapy and Tissue Engineering Market Trends
Table 11. Cell Therapy and Tissue Engineering Market Drivers
Table 12. Cell Therapy and Tissue Engineering Market Challenges
Table 13. Cell Therapy and Tissue Engineering Market Restraints
Table 14. Global Cell Therapy and Tissue Engineering Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cell Therapy and Tissue Engineering Revenue Share by Players (2019-2024)
Table 16. Global Top Cell Therapy and Tissue Engineering by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2023)
Table 17. Global Cell Therapy and Tissue Engineering Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Cell Therapy and Tissue Engineering Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Cell Therapy and Tissue Engineering, Headquarters and Area Served
Table 20. Global Key Players of Cell Therapy and Tissue Engineering, Product and Application
Table 21. Global Key Players of Cell Therapy and Tissue Engineering, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2019-2024)
Table 25. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cell Therapy and Tissue Engineering Revenue Market Share by Type (2025-2030)
Table 27. Global Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cell Therapy and Tissue Engineering Revenue Share by Application (2019-2024)
Table 29. Global Cell Therapy and Tissue Engineering Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cell Therapy and Tissue Engineering Revenue Share by Application (2025-2030)
Table 31. North America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Cell Therapy and Tissue Engineering Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Cell Therapy and Tissue Engineering Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size by Country (2025-2030) & (US$ Million)
Table 63. Betalin Therapeutics Company Details
Table 64. Betalin Therapeutics Business Overview
Table 65. Betalin Therapeutics Cell Therapy and Tissue Engineering Product
Table 66. Betalin Therapeutics Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 67. Betalin Therapeutics Recent Developments
Table 68. BioCardia, Inc Company Details
Table 69. BioCardia, Inc Business Overview
Table 70. BioCardia, Inc Cell Therapy and Tissue Engineering Product
Table 71. BioCardia, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 72. BioCardia, Inc Recent Developments
Table 73. BioReliance Corporation Company Details
Table 74. BioReliance Corporation Business Overview
Table 75. BioReliance Corporation Cell Therapy and Tissue Engineering Product
Table 76. BioReliance Corporation Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 77. BioReliance Corporation Recent Developments
Table 78. Biosolution Co. Company Details
Table 79. Biosolution Co. Business Overview
Table 80. Biosolution Co. Cell Therapy and Tissue Engineering Product
Table 81. Biosolution Co. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 82. Biosolution Co. Recent Developments
Table 83. Brainstorm Cell Therapeutics, Inc Company Details
Table 84. Brainstorm Cell Therapeutics, Inc Business Overview
Table 85. Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 86. Brainstorm Cell Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 87. Brainstorm Cell Therapeutics, Inc Recent Developments
Table 88. MaxCyte, Inc Company Details
Table 89. MaxCyte, Inc Business Overview
Table 90. MaxCyte, Inc Cell Therapy and Tissue Engineering Product
Table 91. MaxCyte, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 92. MaxCyte, Inc Recent Developments
Table 93. Medigene AG Company Details
Table 94. Medigene AG Business Overview
Table 95. Medigene AG Cell Therapy and Tissue Engineering Product
Table 96. Medigene AG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 97. Medigene AG Recent Developments
Table 98. MEDIPOST CO. Company Details
Table 99. MEDIPOST CO. Business Overview
Table 100. MEDIPOST CO. Cell Therapy and Tissue Engineering Product
Table 101. MEDIPOST CO. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 102. MEDIPOST CO. Recent Developments
Table 103. Mesoblast Limited Company Details
Table 104. Mesoblast Limited Business Overview
Table 105. Mesoblast Limited Cell Therapy and Tissue Engineering Product
Table 106. Mesoblast Limited Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 107. Mesoblast Limited Recent Developments
Table 108. Miromatrix Medical, Inc. Company Details
Table 109. Miromatrix Medical, Inc. Business Overview
Table 110. Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Product
Table 111. Miromatrix Medical, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 112. Miromatrix Medical, Inc. Recent Developments
Table 113. MolMed S.p.A Company Details
Table 114. MolMed S.p.A Business Overview
Table 115. MolMed S.p.A Cell Therapy and Tissue Engineering Product
Table 116. MolMed S.p.A Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 117. MolMed S.p.A Recent Developments
Table 118. Mustang Bio, Inc Company Details
Table 119. Mustang Bio, Inc Business Overview
Table 120. Mustang Bio, Inc Cell Therapy and Tissue Engineering Product
Table 121. Mustang Bio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 122. Mustang Bio, Inc Recent Developments
Table 123. NantKwest, Inc. Company Details
Table 124. NantKwest, Inc. Business Overview
Table 125. NantKwest, Inc. Cell Therapy and Tissue Engineering Product
Table 126. NantKwest, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 127. NantKwest, Inc. Recent Developments
Table 128. Neuralstem, Inc Company Details
Table 129. Neuralstem, Inc Business Overview
Table 130. Neuralstem, Inc Cell Therapy and Tissue Engineering Product
Table 131. Neuralstem, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 132. Neuralstem, Inc Recent Developments
Table 133. NexImmune, Inc. Company Details
Table 134. NexImmune, Inc. Business Overview
Table 135. NexImmune, Inc. Cell Therapy and Tissue Engineering Product
Table 136. NexImmune, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 137. NexImmune, Inc. Recent Developments
Table 138. Nohla Therapeutics, Inc Company Details
Table 139. Nohla Therapeutics, Inc Business Overview
Table 140. Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 141. Nohla Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 142. Nohla Therapeutics, Inc Recent Developments
Table 143. ReNeuron Group plc Company Details
Table 144. ReNeuron Group plc Business Overview
Table 145. ReNeuron Group plc Cell Therapy and Tissue Engineering Product
Table 146. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 147. ReNeuron Group plc Recent Developments
Table 148. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 149. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 150. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product
Table 151. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 152. Richter-Helm BioLogics GmbH & Co. KG Recent Developments
Table 153. RoosterBio, Inc Company Details
Table 154. RoosterBio, Inc Business Overview
Table 155. RoosterBio, Inc Cell Therapy and Tissue Engineering Product
Table 156. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 157. RoosterBio, Inc Recent Developments
Table 158. RoslinCT Company Details
Table 159. RoslinCT Business Overview
Table 160. RoslinCT Cell Therapy and Tissue Engineering Product
Table 161. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 162. RoslinCT Recent Developments
Table 163. Rubius Therapeutics, Inc. Company Details
Table 164. Rubius Therapeutics, Inc. Business Overview
Table 165. Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Product
Table 166. Rubius Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 167. Rubius Therapeutics, Inc. Recent Developments
Table 168. Sangamo Therapeutics, Inc Company Details
Table 169. Sangamo Therapeutics, Inc Business Overview
Table 170. Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 171. Sangamo Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 172. Sangamo Therapeutics, Inc Recent Developments
Table 173. Voyager Therapeutics, Inc Company Details
Table 174. Voyager Therapeutics, Inc Business Overview
Table 175. Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Product
Table 176. Voyager Therapeutics, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 177. Voyager Therapeutics, Inc Recent Developments
Table 178. Waisman Biomanufacturing Company Details
Table 179. Waisman Biomanufacturing Business Overview
Table 180. Waisman Biomanufacturing Cell Therapy and Tissue Engineering Product
Table 181. Waisman Biomanufacturing Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 182. Waisman Biomanufacturing Recent Developments
Table 183. WindMIL Therapeutics, Inc. Company Details
Table 184. WindMIL Therapeutics, Inc. Business Overview
Table 185. WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Product
Table 186. WindMIL Therapeutics, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 187. WindMIL Therapeutics, Inc. Recent Developments
Table 188. Wuxi App Tec, Inc. Company Details
Table 189. Wuxi App Tec, Inc. Business Overview
Table 190. Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Product
Table 191. Wuxi App Tec, Inc. Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 192. Wuxi App Tec, Inc. Recent Developments
Table 193. ReNeuron Group plc Company Details
Table 194. ReNeuron Group plc Business Overview
Table 195. ReNeuron Group plc Cell Therapy and Tissue Engineering Product
Table 196. ReNeuron Group plc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 197. ReNeuron Group plc Recent Developments
Table 198. Richter-Helm BioLogics GmbH & Co. KG Company Details
Table 199. Richter-Helm BioLogics GmbH & Co. KG Business Overview
Table 200. Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Product
Table 201. Richter-Helm BioLogics GmbH & Co. KG Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 202. Richter-Helm BioLogics GmbH & Co. KG Recent Developments
Table 203. RoosterBio, Inc Company Details
Table 204. RoosterBio, Inc Business Overview
Table 205. RoosterBio, Inc Cell Therapy and Tissue Engineering Product
Table 206. RoosterBio, Inc Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 207. RoosterBio, Inc Recent Developments
Table 208. RoslinCT Company Details
Table 209. RoslinCT Business Overview
Table 210. RoslinCT Cell Therapy and Tissue Engineering Product
Table 211. RoslinCT Revenue in Cell Therapy and Tissue Engineering Business (2019-2024) & (US$ Million)
Table 212. RoslinCT Recent Developments
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Cell Therapy and Tissue Engineering Market Share by Type: 2023 VS 2030
Figure 3. Cell Therapy Features
Figure 4. Tissue Engineering Features
Figure 5. Global Cell Therapy and Tissue Engineering Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Cell Therapy and Tissue Engineering Market Share by Application: 2023 VS 2030
Figure 7. Cell Defects Case Studies
Figure 8. Genetic Diseases Case Studies
Figure 9. Neurodegenerative Diseases Case Studies
Figure 10. Tissue Malignancies Case Studies
Figure 11. Others Case Studies
Figure 12. Cell Therapy and Tissue Engineering Report Years Considered
Figure 13. Global Cell Therapy and Tissue Engineering Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cell Therapy and Tissue Engineering Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cell Therapy and Tissue Engineering Market Share by Region: 2023 VS 2030
Figure 16. Global Cell Therapy and Tissue Engineering Market Share by Players in 2023
Figure 17. Global Top Cell Therapy and Tissue Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy and Tissue Engineering as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cell Therapy and Tissue Engineering Revenue in 2023
Figure 19. North America Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 21. North America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 22. North America Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)
Figure 23. United States Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 27. Europe Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 28. Europe Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)
Figure 29. Germany Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 37. China Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 38. Asia Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 40. Asia Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 41. Asia Cell Therapy and Tissue Engineering Market Share by Region (2019-2030)
Figure 42. Japan Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Cell Therapy and Tissue Engineering Market Share by Country (2019-2030)
Figure 52. Brazil Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Cell Therapy and Tissue Engineering Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Betalin Therapeutics Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 59. BioCardia, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 60. BioReliance Corporation Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 61. Biosolution Co. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 62. Brainstorm Cell Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 63. MaxCyte, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 64. Medigene AG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 65. MEDIPOST CO. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 66. Mesoblast Limited Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 67. Miromatrix Medical, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 68. MolMed S.p.A Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 69. Mustang Bio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 70. NantKwest, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 71. Neuralstem, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 72. NexImmune, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 73. Nohla Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 74. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 75. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 76. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 77. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 78. Rubius Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 79. Sangamo Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 80. Voyager Therapeutics, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 81. Waisman Biomanufacturing Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 82. WindMIL Therapeutics, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 83. Wuxi App Tec, Inc. Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 84. ReNeuron Group plc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 85. Richter-Helm BioLogics GmbH & Co. KG Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 86. RoosterBio, Inc Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 87. RoslinCT Revenue Growth Rate in Cell Therapy and Tissue Engineering Business (2019-2024)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Anesthetic Market Insights, Forecast to 2030
Dec 27, 24
Global Anaesthetic Medicines Market Insights, Forecast to 2030
Dec 27, 24
Global Air Separation Machinery Market Insights, Forecast to 2030
Dec 27, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232